14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CERU
Delisted

Cerulean Pharma Inc. Fund Predictions

$0.660
+0 (+0%)
At Close: Jan 16, 2018
Currently predicting for Mon, 20 May 2024

CERU Predictions History

7 years ago
JS predicted that CERU for 2017-03-29 is going $0.745 (-18.13%)

7 years ago
Ni.Wr.3109 predicted that CERU for 2017-03-27 is going $0.730 (5.80%)

Rank:

7 years ago
Joey.Samohod.4983 predicted that CERU for 2017-03-27 is going $0.89 (22.76%)

Rank:

7 years ago
JS predicted that CERU for 2017-03-27 is going $0.725 (0.00%)

7 years ago
Jack.Cesario.Migueis.3576 predicted that CERU for 2017-03-27 is going $0.99 (36.41%)

7 years ago
JS predicted that CERU for 2017-03-24 is going $0.770 (6.21%)

7 years ago
Ni.Wr.3109 predicted that CERU for 2017-03-24 is going $0.650 (-12.16%)

Rank:

7 years ago
Shikhar.Khare.4781 predicted that CERU for 2017-03-24 is going $1.60 (116.22%)

Rank:

7 years ago
kexinger predicted that CERU for 2017-03-24 is going $0.80 (8.11%)

Rank:

7 years ago
Jack.Cesario.Migueis.3576 predicted that CERU for 2017-03-24 is going $1.23 (66.22%)

Click to get the best stock tips daily for free!

About Cerulean Pharma Inc.

Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The company’s lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301... CERU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT